Hungary plans new pharma taxes, price cuts

Hungary's government plans to raise taxes on drug companies and cut price subsidies to plug a 25.9 billion forint ($141.5 million) hole in the state drug fund and reduce the deficit, a document obtained by Reuters revealed. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.